Moreover, in the context of immune thrombocytopenia (ITP), researchers have developed a novel chimeric autoantibody receptor targeting glycoprotein (GP) Ibα (GP Ibα-CAAR T cells). The gene discussed is GP1BA; the disease is autoimmune thrombocytopenic purpura.